1. Home
  2. OSCR vs HALO Comparison

OSCR vs HALO Comparison

Compare OSCR & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oscar Health Inc.

OSCR

Oscar Health Inc.

HOLD

Current Price

$30.92

Market Cap

10.0B

Sector

Finance

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$125.99

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSCR
HALO
Founded
2012
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Accident &Health Insurance
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0B
12.0B
IPO Year
2021
2001

Fundamental Metrics

Financial Performance
Metric
OSCR
HALO
Price
$30.92
$125.99
Analyst Decision
Hold
Buy
Analyst Count
11
9
Target Price
$36.40
★ $108.78
AVG Volume (30 Days)
★ 4.2M
2.2M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 3.16
3.11
Revenue
★ $11,701,427,000.00
$151,862,000.00
Revenue This Year
$60.08
$34.69
Revenue Next Year
$10.95
$11.65
P/E Ratio
★ $10.52
$39.88
Revenue Growth
★ 27.50
N/A
52 Week Low
$10.69
$61.23
52 Week High
$35.01
$125.43

Technical Indicators

Market Signals
Indicator
OSCR
HALO
Relative Strength Index (RSI) 42.40 74.21
Support Level $28.16 $105.27
Resistance Level $32.73 N/A
Average True Range (ATR) 1.45 3.51
MACD -0.13 1.11
Stochastic Oscillator 0.70 99.04

Price Performance

Historical Comparison
OSCR
HALO

About OSCR Oscar Health Inc.

Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: